Correspondence and General Collaboration Papers 1994

Correspondence relates to trial press releases, urgency to progress trials due to competing pharmaceutical company developments, Lancet publications, Centocor collaboration with Prof N Voiteniok, patent filing, licensing agreement, phase III of trials and Kennedy Institute trial related memorandums.

See SA/KET/A/2/1 for an overview of the Centocor correspondence, general papers and list of main correspondence contributors.

See SA/KET/A/1 for papers on Centocor sponsored clinical studies/trials.

Item contains some duplicate correspondence.

1994

1 file (in 2 parts)

This item requires facilitated access. Email library@wellcomecollection.org to request an appointment. This item is also restricted. You will need to complete a Restricted Access form agreeing to anonymise personal data before you will be allowed to view this item. Please see our Access Policy for more details. Restricted until 1 January 2055.